Insulin resistance and nonalcoholic steatohepatitis: Fat or fiction?

American Journal of Gastroenterology

Volumn 96, Issue 2, 2001, Pages 274-276

  Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; TROGLITAZONE;

DIABETES MELLITUS; EDITORIAL; FATTY ACID OXIDATION; FATTY LIVER; HEPATITIS; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPOLYSIS; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; OBESITY; PRIORITY JOURNAL; SYNDROME X;

EID: 0035126602     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02341-8     Document Type: Editorial

References (22)

1. Nonalcoholic steatohepatitis: An expanded clinical entity
2. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
3. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis
4. Syndrome X: 10 years after
5. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people
6. Association of nonalcoholic fatty liver disease with insulin resistance
7. Insulin effects on substrate metabolism
8. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
9. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver
10. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study
11. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
12. Mitochondrial abnormalities in non-alcoholic steatohepatitis
13. Hepatotoxicity due to mitochondrial dysfunction
14. Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats
15. Effects of troglitazone on substrate storage and utilization in insulin-resistant rats
16. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes
17. Nonalcoholic steatohepatitis in obesity: A reversible condition
18. Effect of moderate exercise on insulin sensitivity and substrate metabolism during post-exercise recovery in cirrhosis
19. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
20. Metformin reverses fatty liver disease in obese, leptin-deficient mice
21. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
22. Hepatic failure in a patient taking rosiglitazone